Clinical Trials Browser

Phase 1/2 × Locally Advanced Gastric Carcinoma × Bevacizumab × Clear all

NCT02048540 2014-04-25

Neoadjuvant Bev Plus DOF vs DOF in LAGC and Its Association With Circulating Tumor Cell

Phase 1/2 Completed

Gastrointestinal

Locally Advanced Gastric Carcinoma